Loading...
INmune Bio, Inc.
INMB•NASDAQ
Healthcare
Biotechnology
$2.31
$-3.02(-56.66%)
INmune Bio, Inc. (INMB) Quarterly Earnings Reports & Financial Results
Analyze INmune Bio, Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of INmune Bio, Inc.’s actual vs. estimated earnings across recent quarters.
No data available
INmune Bio, Inc. (INMB) Quarterly Earnings Details
Detailed breakdown of INmune Bio, Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.